SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006688
Filing Date
2024-05-06
Accepted
2024-05-03 21:25:11
Documents
15
Period of Report
2024-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gdnsf-20240430x8k.htm   iXBRL 8-K 52306
2 EX-99.1 gdnsf-20240430xex99d1.htm EX-99.1 28632
3 GRAPHIC gdnsf-20240430xex99d1001.gif GRAPHIC 45
  Complete submission text file 0001558370-24-006688.txt   203543

Data Files

Seq Description Document Type Size
4 EX-101.SCH gdnsf-20240430.xsd EX-101.SCH 3415
5 EX-101.LAB gdnsf-20240430_lab.xml EX-101.LAB 14096
6 EX-101.PRE gdnsf-20240430_pre.xml EX-101.PRE 9208
18 EXTRACTED XBRL INSTANCE DOCUMENT gdnsf-20240430x8k_htm.xml XML 4313
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 24915320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)